2,925 research outputs found
Suramin inhibits the early effects of PLA(2) neurotoxins at mouse neuromuscular junctions: a twitch tension study
Several phospholipase A(2) (PLA(2)) neurotoxins from snake venoms can affect acetylcholine release at the neuromuscular junction. In isolated nerve-muscle preparations three distinct phases have been described for this phenomenon: An initial transient decrease in twitch tension; a second facilitatory phase during which twitch height is greater than control twitch height; and the last phase which causes a reduction in twitch height that finally results in paralysis. Suramin has been reported to inhibit the toxic effects of β-bungarotoxin and another PLA(2) neurotoxin, crotoxin in vitro and in vivo. We have further examined the effects of suramin on the three phases of the effects of the presynaptic PLA(2) neurotoxins β-bungarotoxin, taipoxin and ammodytoxin on mouse phrenic nerve-hemidiaphragm preparations. When preparations were pre-treated with suramin (0.3mM), the early biphasic effects (depression followed by facilitation) were abolished, and the time taken for final blockade induced by β-bungarotoxin, taipoxin and ammodytoxin A was significantly prolonged. In contrast, suramin did not significantly affect the facilitation induced by the potassium channel blocking toxin dendrotoxin I when applied under the same conditions. In addition, application of 0.3mM suramin did not prevent the facilitatory actions of 3,4-diaminopyridine (3,4-DAP) and tetraethylammonium chloride (TEA). Overall, the mechanism whereby suramin reduces the effects of PLA(2) neurotoxins remains elusive. Since suramin reduces both enzyme-dependent and enzyme-independent effects of the toxins, suramin is not acting as a simple enzyme inhibitor. Furthermore, the observation that suramin does not affect actions of standard K(+) channel blockers suggests that suramin does not stabilise nerve terminals
Four-part differential leukocyte count using μflow cytometer
This paper reports the four-part differential leukocyte
count (DLC) of human blood using a MEMS
microflow (μflow) cytometer. It is achieved with a
two-color laser-induced fluorescence (LIF) detection
scheme. Four types of leukocytes including
neutrophils, eosinophils, lymphocytes and monocytes
are identified in blood samples, which are stained by
fluorescein isothiocyanate (FITC) and propidium
iodide (PI). The DLC results show good correlation
with the count from a commercial hematology
analyzer. The whole system is also implemented into a
portable instrument for space application
Efecto inhibitorio de un extracto acuoso de las hojas de Allophylus cominia (L.) Sw sobre las proteínas tirosina fosfatasa 1B y dipeptidil peptidasa IV
Introduction: Allophylus cominia (L.) Sw is a Cuban medicinal plant used by traditional medicine for the treatment of diabetes with unknown mechanisms of action. Objective: to evaluate the effect of Allophylus cominia (L.) Sw leaves aqueous extract and its fractions on protein tyrosine phosphatase 1B (PTP1B) and dipeptidyl peptidase IV (DPPIV) enzymatic activity, as therapeutic targets of type 2 diabetes. Methods: the aqueous extract of A. cominia leaves was successively partitioned with organic solvents mixtures, thus increasing polarity in order to obtain ten fractions. The extract and its fractions were tested for their possible antidiabetic activity on therapeutic targets of type 2 diabetes: PTP1B and DPPIV. The enzymatic inhibition assays were performed and the inhibitory activity was calculated with the fluorescence values using an excitation wavelength of 360 nm and an emission wavelength of 460 nm. Results: the aqueous extract from A. cominia inhibited the enzymatic activity of PTP1B and DPPIV according to the concentration, being IC50 values equal to 0.69 μg/mL and 344.3 μg/mL, respectively. Several fractions were detected as potent PTP1B inhibitors. The most polar fractions AcF9 and AcF10 were more active, showing IC50 values of 4.4 µg/mL and 3.8 µg/mL respectively. The fractions showed a slight DPPIV inhibition, being fractions AcF6, AcF9 and AcF10 the most active, exhibiting inhibition percentages of 52.0 %, 39.0 % and 40.0 % respectively. Conclusions: A. cominia aqueous extract and its polar fractions (AcF9 and AcF10) have antidiabetic properties in vitro and are promissory candidates for development of new drugs with inhibitory activity of PTP1B and DPPIV for type 2 diabetes treatment
Bringing Agriculture into the GATT: Designing Acceptable Agricultural Policies
Agricultural and Food Policy, International Relations/Trade,
Usefulness of electrophysiologic study to determine the clinical tolerance of arrhythmia recurrences during amiodarone therapy
The relation of clinical and electrophysiologic variables to outcome was evaluated in 121 patients treated with amiodarone for sustained ventricular tachyarrhythmias. Electrophysiologic study was performed in all patients a mean of 14 days after beginning amiodarone therapy. Forty-six patients who were given oral amiodarone therapy experienced arrhythmia recurrence. Multivariate analysis was performed using 16 clinical and electrophysiologic variables to determine which factors were associated with 1) arrhythmia recurrence and 2) a poorly tolerated arrhythmia recurrence (that is, cardiac arrest or sudden cardiac death) during oral amiodarone therapy. No variable predicted arrhythmia recurrence. Five variables correlated significantly with a poorly tolerated arrhythmia recurrence. Hemodynamic stability of the arrhythmia induced on electrophysiologic testing during amiodarone therapy had the best predictive value (p < 0.001). Younger age, lower ejection fraction, a poorly tolerated rhythm at clinical presentation and absence of left ventricular aneurysm were also associated with a poorly tolerated arrhythmia recurrence.Only 3 of 57 patients who had a well tolerated arrhythmia induced on electrophysiologic testing during amiodarone therapy had recurrence of a poorly tolerated arrhythmia versus 19 of 47 who had hemodynamically unstable arrhythmias induced during amiodarone therapy (p < 0.001). Thus, electrophysiologic testing during amiodarone therapy appears useful in identifying patients who are prone to have catastrophic arrhythmia recurrences and could allow for the institution of additional or alternative modes of therapy
Density Variations in the NW Star Stream of M31
The Pan Andromeda Archeological Survey (PAndAS) CFHT Megaprime survey of the
M31-M33 system has found a star stream which extends about 120 kpc NW from the
center of M31. The great length of the stream, and the likelihood that it does
not significantly intersect the disk of M31, means that it is unusually well
suited for a measurement of stream gaps and clumps along its length as a test
for the predicted thousands of dark matter sub-halos. The main result of this
paper is that the density of the stream varies between zero and about three
times the mean along its length on scales of 2 to 20 kpc. The probability that
the variations are random fluctuations in the star density is less than 10^-5.
As a control sample we search for density variations at precisely the same
location in stars with metallicity higher than the stream, [Fe/H]=[0, -0.5] and
find no variations above the expected shot noise. The lumpiness of the stream
is not compatible with a low mass star stream in a smooth galactic potential,
nor is it readily compatible with the disturbance caused by the visible M31
satellite galaxies. The stream's density variations appear to be consistent
with the effects of a large population of steep mass function dark matter
sub-halos, such as found in LCDM simulations, acting on an approximately 10Gyr
old star stream. The effects of a single set of halo substructure realizations
are shown for illustration, reserving a statistical comparison for another
study.Comment: ApJ revised version submitte
The Primordial Inflation Polarization Explorer (PIPER)
The Primordial Inflation Polarization Explorer (PIPER) is a balloon-borne
cosmic microwave background (CMB) polarimeter designed to search for evidence
of inflation by measuring the large-angular scale CMB polarization signal.
BICEP2 recently reported a detection of B-mode power corresponding to the
tensor-to-scalar ratio r = 0.2 on ~2 degree scales. If the BICEP2 signal is
caused by inflationary gravitational waves (IGWs), then there should be a
corresponding increase in B-mode power on angular scales larger than 18
degrees. PIPER is currently the only suborbital instrument capable of fully
testing and extending the BICEP2 results by measuring the B-mode power spectrum
on angular scales = ~0.6 deg to 90 deg, covering both the reionization
bump and recombination peak, with sensitivity to measure the tensor-to-scalar
ratio down to r = 0.007, and four frequency bands to distinguish foregrounds.
PIPER will accomplish this by mapping 85% of the sky in four frequency bands
(200, 270, 350, 600 GHz) over a series of 8 conventional balloon flights from
the northern and southern hemispheres. The instrument has background-limited
sensitivity provided by fully cryogenic (1.5 K) optics focusing the sky signal
onto four 32x40-pixel arrays of time-domain multiplexed Transition-Edge Sensor
(TES) bolometers held at 140 mK. Polarization sensitivity and systematic
control are provided by front-end Variable-delay Polarization Modulators
(VPMs), which rapidly modulate only the polarized sky signal at 3 Hz and allow
PIPER to instantaneously measure the full Stokes vector (I, Q, U, V) for each
pointing. We describe the PIPER instrument and progress towards its first
flight.Comment: 11 pages, 7 figures. To be published in Proceedings of SPIE Volume
9153. Presented at SPIE Astronomical Telescopes + Instrumentation 2014,
conference 915
Using Complexity and Network Concepts to Inform Healthcare Knowledge Translation
Published by Kerman University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly citedMany representations of the movement of healthcare knowledge through society exist, and multiple models for the translation of evidence into policy and practice have been articulated. Most are linear or cyclical and very few come close to reflecting the dense and intricate relationships, systems and politics of organizations and the processes required to enact sustainable improvements. We illustrate how using complexity and network concepts can better inform knowledge translation (KT) and argue that changing the way we think and talk about KT could enhance the creation and movement of knowledge throughout those systems needing to develop and utilise it. From our theoretical refinement, we propose that KT is a complex network composed of five interdependent sub-networks, or clusters, of key processes (problem identification [PI], knowledge creation [KC], knowledge synthesis [KS], implementation [I], and evaluation [E]) that interact dynamically in different ways at different times across one or more sectors (community; health; government; education; research for example). We call this the KT Complexity Network, defined as a network that optimises the effective, appropriate and timely creation and movement of knowledge to those who need it in order to improve what they do. Activation within and throughout any one of these processes and systems depends upon the agents promoting the change, successfully working across and between multiple systems and clusters. The case is presented for moving to a way of thinking about KT using complexity and network concepts. This extends the thinking that is developing around integrated KT approaches. There are a number of policy and practice implications that need to be considered in light of this shift in thinking
The Ribosome Biogenesis Protein Nol9 Is Essential for Definitive Hematopoiesis and Pancreas Morphogenesis in Zebrafish.
Ribosome biogenesis is a ubiquitous and essential process in cells. Defects in ribosome biogenesis and function result in a group of human disorders, collectively known as ribosomopathies. In this study, we describe a zebrafish mutant with a loss-of-function mutation in nol9, a gene that encodes a non-ribosomal protein involved in rRNA processing. nol9sa1022/sa1022 mutants have a defect in 28S rRNA processing. The nol9sa1022/sa1022 larvae display hypoplastic pancreas, liver and intestine and have decreased numbers of hematopoietic stem and progenitor cells (HSPCs), as well as definitive erythrocytes and lymphocytes. In addition, ultrastructural analysis revealed signs of pathological processes occurring in endothelial cells of the caudal vein, emphasizing the complexity of the phenotype observed in nol9sa1022/sa1022 larvae. We further show that both the pancreatic and hematopoietic deficiencies in nol9sa1022/sa1022 embryos were due to impaired cell proliferation of respective progenitor cells. Interestingly, genetic loss of Tp53 rescued the HSPCs but not the pancreatic defects. In contrast, activation of mRNA translation via the mTOR pathway by L-Leucine treatment did not revert the erythroid or pancreatic defects. Together, we present the nol9sa1022/sa1022 mutant, a novel zebrafish ribosomopathy model, which recapitulates key human disease characteristics. The use of this genetically tractable model will enhance our understanding of the tissue-specific mechanisms following impaired ribosome biogenesis in the context of an intact vertebrate.The study was supported by Cancer Research UK (grant number C45041/A14953 to AC and LF), Wellcome Trust (grants number 084183/Z/07/Z to EBM and number 098051 to DLS and LLH), Specialist Programme from Bloodwise [12048], the Medical Research Council [MC_U105161083] and Ted’s Gang (to AJW), a Wellcome Trust strategic award to the Cambridge Institute for Medal Research [100140] and the Cambridge NIHR Biomedical Research Centre (to AJW and AC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.This is the final version of the article. It was first available from PLOS via http://dx.doi.org/10.1371/journal.pgen.100567
- …